CHM Cannabis
Home > Boards > US Listed > Biotechs >

Neptune tech and Bio-Resources (NEPT)

Add NEPT Price Alert      Hide Sticky   Hide Intro
Moderator: Walterwhite666
Search This Board: 
Last Post: 12/15/2018 12:18:57 AM - Followers: 42 - Board type: Free - Posts Today: 0


I first heard about this stock when it was trading at the $2.32 mark a few weeks ago. Now we're hearing that more institutional buying and high profile firms are getting ready to take positions. That, in-turn, should lead to even more buying by retail investors. It's the stock snowball and visibility effect and this company deserves it 

About Neptune

Neptune Technologies & Bioressources Inc. researches, develops and commercializes proprietary bioactive ingredients and products with superior added-value and clinically proven health benefits. The Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune's first commercially available product is Neptune Krill Oil (NKO®), which represents the only clinically proven and scientifically acknowledged marine omega-3 phospholipids with cardiovascular, cognitive and anti-inflammatory benefits for human applications and which exhibits unmet safety, purity and stability and consequently denoting a new level of excellence in omega-3 standards.

Neptune is pursuing market opportunities in the nutraceutical market including dietary supplements and functional foods. The Company is benefiting from opportunities in the pharmaceutical market through its pharmaceutical subsidiaries Acasti Pharma and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).

The Mission of Neptune is to:

  • Research, Develop and Commercialize Novel Marine Bioactive Ingredients
  • Pursue opportunities in the nutraceutical markets
    • Dietary Supplement
    • Functional Food
  • Exploit pharmaceutical applications
    • Subsidiary Acasti Pharma Inc: Cardiovascular diseases
    • Subsidiary NeuroBioPharm Inc.: Neurodegenerative diseases
  • Validate Superiority, Safety & Effectiveness
  • Protect Intellectual Property
  •   Enter Commercialization Alliances and Partnership Licenses

Promising results from A new cholesterol drug have helped call attention to Neptune, which is aiming for cholesterol/hyperlipidemia's ultimate prize, but unlike most companies dealing with clinical studies and regulatory approvals, Neptune is a revenue generating company whose products are already marketed and distributed in over 20 countries worldwide.

The Versant Partners' report, subtitled: "Krill oil franchise poised to outperform in multiple consumer and medical markets" features a few key points of note.

With NEPT's fiscal year end being February, Mr. Loe is calling for:

* F2012 revenues of $21.79 million and earnings $4.34 million ($0.09 EPS)
* F2013 revenues of $32.39 million and earnings of $8.81 million ($0.17 EPS)
* F2014 revenues of $45.37 million and earnings of $15.69 million ($0.30 EPS)
Loe cited management plans to meet forecasted demand by increasing current plant production from 130 thousand kilograms of krill oil per year to 430 thousand kilograms per year by 2015, a 300% production increase.
The report pinned its share price targets not only on the business Neptune has in hand, but also its future. By far, the biggest foundation Mr. Loe constructed on which to base his conclusions came from his meticulous research into the product itself - Neptune Krill Oil or NKO as it is branded on the market - and all its further refined products, such as Acasti's drug candidate called 'CaPre'.

Along the way, Loe also gives a significant nod to the functional food alliances Neptune developed with Yoplait - which is 50% owned by General Mills - and the food manufacturing behemoth, Nestle.

Mr. Loe wrote that both Yoplait and Nestle "should conclude development," of their research into Neptune Krill Oil by the end of the current year and that assuming all goes well, the sales of krill-oil infused food products by these giants would be a major revenue driver for Neptune in 2013/14  About Acasti

Acasti Pharma is developing safe and effective pharmaceutical and medical applications with an initial focus on cardiovascular disease by leveraging the intellectual property, clinical data and know how developed by Neptune Technologies. The Company is advancing a portfolio of bioactive ingredients of proprietary novel omega-3 phospholipids through the pharmaceutical development pathway which includes prescription medical foods (MF), over-the-counter products (OTC), and prescription drugs (Rx). Phospholipids are the major component of cell membranes and essential for all vital cell processes. They are one of the principle constituents of High Density Lipoprotein (good cholesterol) and play, as such, an important role in modulating cholesterol efflux.

Acasti Pharma's proprietary novel phospholipids carry and functionalize the polyunsaturated omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) stabilized by potent antioxidants. Evidence has demonstrated the anti-inflammatory properties of EPA and DHA regulating important biological functions including degenerative, arthritic, circulatory, digestive, and brain diseases. Delivering omega-3s functionalized on phospholipids helps optimize the omega-3 fatty acid therapeutic benefits. Potent antioxidants contribute to proper physiological regulation preventing free radical cellular damage, a common pathway for cardiovascular disease and inflammation as well as neurodegenerative disease 


CHM Cannabis
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NEPT News: Report of Foreign Issuer (6-k) 11/26/2018 07:55:08 AM
NEPT News: Neptune participera à deux conférences cet automne 11/26/2018 07:30:00 AM
NEPT News: Neptune to Participate in Fall 2018 Investor Conferences 11/26/2018 07:30:00 AM
NEPT News: Neptune to Participate in Fall 2018 Investor Conferences 11/26/2018 07:30:00 AM
NEPT News: Report of Foreign Issuer (6-k) 11/13/2018 04:23:55 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#338   It's not, downward slide Scooter79 12/15/18 12:18:57 AM
#337   When’s the omega 3 patent and health Canada Tdogwm 11/12/18 08:58:59 AM
#336   40-F said 180 business days for DL from Yolo14 11/09/18 07:56:45 PM
#335   Thanks Crypto these are the patents I was Biobillionair 11/06/18 08:48:08 AM
#334   Neptune and Aker BioMarine Reach a Patent Agreement Crypto__1 11/05/18 08:29:19 PM
#333   Neptune Wellness Solutions Crypto__1 11/05/18 08:27:04 PM
#332   $NEPT Neptune Files Two Patent Applications for Innovative Crypto__1 11/05/18 08:24:39 PM
#331   Agreed it's coming and I'm loading! $nept Walterwhite666 11/05/18 12:05:30 PM
#330   Thanks, What can you tell me about NEPT Biobillionair 11/04/18 07:42:01 PM
#329   $NEPT Neptune submits evidence package - continues with Crypto__1 11/04/18 07:38:52 PM
#328   Thanks Biobillionair 11/04/18 05:46:25 PM
#327   Within the Next 2 Weeks, I expect to Crypto__1 11/04/18 05:29:09 PM
#326   What's the timeframe on Health Canada approval? Biobillionair 11/04/18 10:10:14 AM
#325   Gonna Breakout w HEALTH CANADA APPROVAL TO PRODUCE Crypto__1 11/02/18 06:33:42 PM
#324   I expect this to be over 10.00 in Walterwhite666 11/02/18 11:59:45 AM
#323   Bids been growing gradually being walked up Walterwhite666 11/02/18 11:59:29 AM
#322   Got some calls here as well as $dtea Walterwhite666 11/02/18 11:58:50 AM
#321   $nept looking good today $nept Walterwhite666 10/30/18 10:14:23 AM
#320   Under The Radar Marijuana Stocks Crypto__1 10/27/18 02:36:25 PM
#319   It's Time to Go All In on Cannabis Crypto__1 10/27/18 12:36:58 PM
#318   https://medium.com/@epicmedia/under-the-radar-marijuana-stocks-f62568a143b3 $nep Walterwhite666 10/25/18 02:12:51 PM
#317   NEWS!! https://www.ftmig.com/cannabis/neptune-to-exhibit-and-present-at-2018-mon Jdoggg 10/22/18 09:23:56 AM
#316   News Alert for Neptune Wellness Solutions Inc. (NEPT) Crypto__1 10/22/18 07:35:23 AM
#315   We are proud to announce that we have Crypto__1 10/21/18 04:34:21 PM
#314   Learn more about #KetoCharged at #SupplysideWest! We will Crypto__1 10/21/18 04:33:03 PM
#313   Come in and see Neptune's world-class facility for Crypto__1 10/21/18 04:30:36 PM
#312   Neptune submitted its complete Evidence Package to Health Crypto__1 10/21/18 04:30:25 PM
#311   Health Canada Approval, expected any day now!! Crypto__1 10/18/18 05:06:28 PM
#310   Looking very strong among the weakness. brimkelly 10/16/18 11:40:43 AM
#309   New HOD :) $NEPT r1aviator 10/15/18 03:18:00 PM
#308   ‘tis the season! $NEPT r1aviator 10/15/18 10:32:12 AM
#307   I think your right, seems to be :) Mototeam 10/15/18 10:30:28 AM
#306   She wants to break out. jmo :) $NEPT r1aviator 10/15/18 10:07:28 AM
#305   The day is young..we still may gain ;) $NEPT r1aviator 10/11/18 10:41:50 AM
#304   My sources were incorrect. My apologies FunkPhilosopher 10/10/18 09:09:38 PM
#303   Been watching a couple months now. CEO will FunkPhilosopher 10/10/18 04:47:08 PM
#302   Right on, just wanted to see the board Mototeam 10/10/18 10:25:08 AM
#301   Waiting with you all. Been here yr. more fuzzychin 10/10/18 09:27:53 AM
#300   Fine by be! $NEPT r1aviator 10/10/18 09:00:52 AM
#299   No kidding. This Stock is gonna blow up Mototeam 10/10/18 07:54:09 AM
#298   Quiet board for what’s happening.. $NEPT r1aviator 10/08/18 02:17:35 PM
#297   Loaded today adtime 10/04/18 05:27:26 PM
#296   ~$600k on-bid $NEPT r1aviator 10/04/18 01:43:24 PM
#295   major-league bids $NEPT r1aviator 10/04/18 01:34:26 PM
#294   Took a starter $NEPT r1aviator 10/04/18 12:51:40 PM
#293   I think that this dip is going to Mototeam 10/04/18 11:21:54 AM
#292   it's quiet in here Mototeam 10/04/18 11:20:13 AM
#291   Invested 50K today nept$4.05going to Neptune growing greene weedtrader420 10/02/18 01:22:17 AM
#290   5.10 post market slyguy8888 10/01/18 05:43:47 PM
#289   * * $NEPT Video Chart 10-01-18 * * ClayTrader 10/01/18 05:24:46 PM